Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,035,263 papers from all fields of science
Search
Sign In
Create Free Account
NCKAP1L gene
Known as:
NCK associated protein 1 like
, HEM1
, NCKAP1L
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation
Carla N. Castro
,
M. Rosenzwajg
,
+33 authors
S. Bahram
Journal of Experimental Medicine
2020
Corpus ID: 221078375
Biallelic mutations in NCKAP1L, a regulator of the actin cytoskeleton, cause immunodeficiency, lymphoproliferation, and…
Expand
2020
2020
The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity
E. Salzer
,
S. Zoghi
,
+26 authors
K. Boztug
Science immunology
2020
Corpus ID: 220473670
HEM1 deficiency causes heritable autoimmunity and immunodeficiency. Tempering lymphocyte activation Diagnosis and treatment of…
Expand
2019
2019
5-Aminolevulinic acid fermentation using engineered Saccharomyces cerevisiae
K. Hara
,
M. Saito
,
+8 authors
A. Kondo
Microbial Cell Factories
2019
Corpus ID: 207944352
Background5′-Aminolevulinic acid (ALA) is widely used in the pharmaceutical industry, healthcare, and food production, and is a…
Expand
Review
2010
Review
2010
Hem‐1: Putting the “WAVE” into actin polymerization during an immune response
Heon Park
,
Maia M. Chan
,
B. Iritani
FEBS Letters
2010
Corpus ID: 29649631
Highly Cited
2008
Highly Cited
2008
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
Heon Park
,
K. Staehling‐Hampton
,
+12 authors
B. Iritani
Journal of Experimental Medicine
2008
Corpus ID: 16577642
Hem1 (Hematopoietic protein 1) is a hematopoietic cell-specific member of the Hem family of cytoplasmic adaptor proteins…
Expand
Highly Cited
2007
Highly Cited
2007
ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia
A. Joshi
,
G. Hegde
,
+9 authors
S. Joshi
Clinical Cancer Research
2007
Corpus ID: 17685913
Purpose: In B-cell chronic lymphocytic leukemia (CLL), high CD38 expression has been associated with unfavorable clinical course…
Expand
2005
2005
Identification of genetic markers for fat deposition and meat tenderness on bovine chromosome 5: development of a low-density single nucleotide polymorphism map.
R. Stone
,
E. Casas
,
+7 authors
W. Snelling
Journal of Animal Science
2005
Corpus ID: 11206097
As genetic markers, SNP are well suited for the development of genetic tests for production traits in livestock. They are stable…
Expand
Highly Cited
2003
Highly Cited
2003
Inhibition of Heme Biosynthesis Prevents Transcription of Iron Uptake Genes in Yeast*
Robert J. Crisp
,
Annette M Pollington
,
C. Galea
,
S. Jaron
,
Y. Yamaguchi-Iwai
,
J. Kaplan
Journal of Biological Chemistry
2003
Corpus ID: 25843878
Yeast are capable of modifying their metabolism in response to environmental changes. We investigated the activity of the oxygen…
Expand
Highly Cited
1987
Highly Cited
1987
Constitutive expression of the yeast HEM1 gene is actually a composite of activation and repression.
T. Keng
,
L. Guarente
Proceedings of the National Academy of Sciences…
1987
Corpus ID: 41821690
We show that HEM1 (encoding 5-aminolevulinate synthase) expression, while constitutive under all steady-state growth conditions…
Expand
1986
1986
The nine amino-terminal residues of delta-aminolevulinate synthase direct beta-galactosidase into the mitochondrial matrix
T. Keng
,
E. Alani
,
L. Guarente
Molecular and Cellular Biology
1986
Corpus ID: 1663388
delta-Aminolevulinate synthase, the first enzyme in the heme biosynthetic pathway, is encoded by the nuclear gene HEM1. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE